000 01797 a2200493 4500
005 20250516082008.0
264 0 _c20120907
008 201209s 0 0 eng d
022 _a1573-7365
024 7 _a10.1007/s11011-012-9289-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBurrows, Gregory G
245 0 0 _aGilt required for RTL550-CYS-MOG to treat experimental autoimmune encephalomyelitis.
_h[electronic resource]
260 _bMetabolic brain disease
_cJun 2012
300 _a143-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAmino Acid Sequence
650 0 4 _aAnimals
650 0 4 _aEncephalomyelitis, Autoimmune, Experimental
_xdrug therapy
650 0 4 _aEndosomes
_xchemistry
650 0 4 _aGenes, MHC Class II
_xgenetics
650 0 4 _aHistocompatibility Antigens Class II
_xtherapeutic use
650 0 4 _aLigands
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Knockout
650 0 4 _aMolecular Sequence Data
650 0 4 _aMycobacterium tuberculosis
_ximmunology
650 0 4 _aOxidoreductases
_xgenetics
650 0 4 _aOxidoreductases Acting on Sulfur Group Donors
650 0 4 _aPeptide Fragments
_xtherapeutic use
650 0 4 _aProtein Engineering
650 0 4 _aRecombinant Proteins
_xtherapeutic use
650 0 4 _aT-Lymphocytes
_xmetabolism
700 1 _aMeza-Romero, Roberto
700 1 _aHuan, Jianya
700 1 _aSinha, Sushmita
700 1 _aMooney, Jeffrey L
700 1 _aVandenbark, Arthur A
700 1 _aOffner, Halina
773 0 _tMetabolic brain disease
_gvol. 27
_gno. 2
_gp. 143-9
856 4 0 _uhttps://doi.org/10.1007/s11011-012-9289-7
_zAvailable from publisher's website
999 _c21598842
_d21598842